4//SEC Filing
Chrousos Phaedra 4
Accession 0001209191-19-025783
CIK 0001347178other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 5:34 PM ET
Size
5.6 KB
Accession
0001209191-19-025783
Insider Transaction Report
Form 4
Chrousos Phaedra
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-04-23+35,000→ 35,000 totalExercise: $17.31Exp: 2029-04-22→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests with respect to 25% of the underlying shares when the Reporting Person completes 12 months of continuous service following the date of grant, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001774518
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 5:34 PM ET
- Size
- 5.6 KB